P
PT UBC Medical Indonesia Tbk
IDX:LABS
PT UBC Medical Indonesia Tbk
IDX:LABS
Price:
163
IDR
-0.61%
Market Cap:
Rp643.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
ID |
|
Genting Bhd
OTC:GEBEY
|
MY |
|
Jack Henry & Associates Inc
NASDAQ:JKHY
|
US |
|
K
|
Kleannara Co Ltd
KRX:004540
|
KR |
|
JW Life Science Corp
KRX:234080
|
KR |
|
Kothari Fermentation and Biochem Ltd
BSE:507474
|
IN |
|
G
|
GenNBio Inc
KOSDAQ:072520
|
KR |
|
K
|
Kyoei Sangyo Co Ltd
TSE:6973
|
JP |
|
A
|
Alpha Pro Tech Ltd
F:APL
|
CA |
|
RGC Resources Inc
NASDAQ:RGCO
|
US |
|
Longevity Health Holdings Inc
NASDAQ:XAGE
|
US |
|
Hindustan Petroleum Corp Ltd
NSE:HINDPETRO
|
IN |
|
D
|
Dayou Automotive Seat Technology Co Ltd
KRX:002880
|
KR |
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
SA |
|
Astec Industries Inc
NASDAQ:ASTE
|
US |
|
Usinas Siderurgicas de Minas Gerais SA USIMINAS
BOVESPA:USIM5
|
BR |
Multiples-Based Value
The Multiples-Based Value for PT UBC Medical Indonesia Tbk (LABS) under the Base Case is hidden IDR. Compared with the current market price of 163 IDR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LABS Multiples-Based Value
LOCKED
Multiples Across Competitors
LABS Competitors Multiples
PT UBC Medical Indonesia Tbk Competitors
PT UBC Medical Indonesia Tbk Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ID |
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
643.9B IDR | 3.6 | 69.2 | 41.4 | 41.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.5B USD | 0.3 | 24.5 | 17.3 | 19.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.4B USD | 0.2 | 38.4 | 13.6 | 17.2 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.6B USD | 0.2 | 38.5 | 13.6 | 17.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.9B USD | 0.2 | 30.6 | 14.8 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.9B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY | 0.2 | 11.1 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 21.9 | 10.8 | 15.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD | 0.1 | 8.2 | 0.7 | 0.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
